827 related articles for article (PubMed ID: 20804570)
1. Breast cancer prognostic classification in the molecular era: the role of histological grade.
Rakha EA; Reis-Filho JS; Baehner F; Dabbs DJ; Decker T; Eusebi V; Fox SB; Ichihara S; Jacquemier J; Lakhani SR; Palacios J; Richardson AL; Schnitt SJ; Schmitt FC; Tan PH; Tse GM; Badve S; Ellis IO
Breast Cancer Res; 2010; 12(4):207. PubMed ID: 20804570
[TBL] [Abstract][Full Text] [Related]
2. Modern classification of breast cancer: should we stick with morphology or convert to molecular profile characteristics.
Rakha EA; Ellis IO
Adv Anat Pathol; 2011 Jul; 18(4):255-67. PubMed ID: 21654357
[TBL] [Abstract][Full Text] [Related]
3. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
Correa Geyer F; Reis-Filho JS
Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
[TBL] [Abstract][Full Text] [Related]
4. Molecular classification of breast cancer.
Vuong D; Simpson PT; Green B; Cummings MC; Lakhani SR
Virchows Arch; 2014 Jul; 465(1):1-14. PubMed ID: 24878755
[TBL] [Abstract][Full Text] [Related]
5. Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.
Colombo PE; Milanezi F; Weigelt B; Reis-Filho JS
Breast Cancer Res; 2011 Jun; 13(3):212. PubMed ID: 21787441
[TBL] [Abstract][Full Text] [Related]
6. Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy.
Schnitt SJ
Mod Pathol; 2010 May; 23 Suppl 2():S60-4. PubMed ID: 20436504
[TBL] [Abstract][Full Text] [Related]
7. [Genome-wide expression profiling as a clinical tool: are we there yet?].
Geyer FC; Decker T; Reis-Filho JS
Pathologe; 2009 Mar; 30(2):141-6. PubMed ID: 19219435
[TBL] [Abstract][Full Text] [Related]
8. Is gene array testing to be considered routine now?
Paik S
Breast; 2011 Oct; 20 Suppl 3():S87-91. PubMed ID: 22015300
[TBL] [Abstract][Full Text] [Related]
9. [Modern pathologic diagnostics in breast cancer].
Szoke J; Udvarhelyi N
Orv Hetil; 2012 Jan; 153(1):22-30. PubMed ID: 22204831
[TBL] [Abstract][Full Text] [Related]
10. Histological types of breast cancer: how special are they?
Weigelt B; Geyer FC; Reis-Filho JS
Mol Oncol; 2010 Jun; 4(3):192-208. PubMed ID: 20452298
[TBL] [Abstract][Full Text] [Related]
11. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
12. Refinement of breast cancer classification by molecular characterization of histological special types.
Weigelt B; Horlings HM; Kreike B; Hayes MM; Hauptmann M; Wessels LF; de Jong D; Van de Vijver MJ; Van't Veer LJ; Peterse JL
J Pathol; 2008 Oct; 216(2):141-50. PubMed ID: 18720457
[TBL] [Abstract][Full Text] [Related]
13. Molecular classification of breast cancer: what the pathologist needs to know.
Rakha EA; Green AR
Pathology; 2017 Feb; 49(2):111-119. PubMed ID: 28040199
[TBL] [Abstract][Full Text] [Related]
14. The role of molecular analysis in breast cancer.
Geyer FC; Marchio C; Reis-Filho JS
Pathology; 2009 Jan; 41(1):77-88. PubMed ID: 19089743
[TBL] [Abstract][Full Text] [Related]
15. Histological and molecular types of breast cancer: is there a unifying taxonomy?
Weigelt B; Reis-Filho JS
Nat Rev Clin Oncol; 2009 Dec; 6(12):718-30. PubMed ID: 19942925
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer expression profiling: the impact of microarray testing on clinical decision making.
Modlich O; Prisack HB; Bojar H
Expert Opin Pharmacother; 2006 Oct; 7(15):2069-78. PubMed ID: 17020433
[TBL] [Abstract][Full Text] [Related]
17. Molecular classification of breast cancer: limitations and potential.
Pusztai L; Mazouni C; Anderson K; Wu Y; Symmans WF
Oncologist; 2006 Sep; 11(8):868-77. PubMed ID: 16951390
[TBL] [Abstract][Full Text] [Related]
18. Pathological controversies in breast cancer: classification of ductal carcinoma in situ, sentinel lymph nodes and low volume metastatic disease and reporting of neoadjuvant chemotherapy specimens.
Provenzano E; Brown JP; Pinder SE
Clin Oncol (R Coll Radiol); 2013 Feb; 25(2):80-92. PubMed ID: 23199579
[TBL] [Abstract][Full Text] [Related]
19. Cancer Grade Model: a multi-gene machine learning-based risk classification for improving prognosis in breast cancer.
Amiri Souri E; Chenoweth A; Cheung A; Karagiannis SN; Tsoka S
Br J Cancer; 2021 Aug; 125(5):748-758. PubMed ID: 34131308
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling in breast cancer: classification, prognostication, and prediction.
Reis-Filho JS; Pusztai L
Lancet; 2011 Nov; 378(9805):1812-23. PubMed ID: 22098854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
